Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lopinavir/Ritonavir vs. Efavirenz in Advanced HIV
NCT00386659Phase 4Terminated
- Sponsor
- Hospital Clínic de Barcelona
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in human immunodeficiency virus infection (HIV) comparing Lopinavir/Ritonavir Arm with Efavirenz Arm (2 arms). Primary endpoint: Proportion of patients with viral load below 20 copies/ml in plasma and lymphoid tissue at 12 months. Status: terminated.
02
Drugs
lopinavirritonavirefavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00386659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00386659.